Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Not Yet Recruiting

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

NCT07476326

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +10 more
Locations: High Technology Hospital Medcenter Batumi, Georgia

JSC Vian Kutaisi, Georgia

Institute of Clinical Oncology - Lubliana Street Tbilisi, Georgia

Israel-Georgian Medical Research Clinic Helsicore Tbilisi, Georgia

View all 26 locations

View Trial Details

Not Yet Recruiting

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

NCT07431216

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma

NCT07501104

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Screening for Brain Metastases

NCT07492121

Conditions: Breast Cancer Metastatic, Lung Cancer Stage IV, Lung Diseases, +17 more
Locations: University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not Yet Recruiting

Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma

NCT07492836

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study for Cerebral Open Flow Microperfusion

NCT07089758

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma

NCT07481721

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

NCT06708455

Conditions: Malignant Melanoma, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV, +13 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Not Yet Recruiting

Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas

NCT07472387

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: Neuro-oncology department, Pitié Salpêtrière hospital Paris, France

View Trial Details

Not Yet Recruiting

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

NCT07475572

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions